Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of “regression to the mean” using routine clinical features with correlating biochemical relapse rates

Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of “regression to the mean” using routine clinical features with correlating biochemical relapse rates

Recommendations for managing clinically localized prostate cancer are structured around clinical risk criteria, with prostate biopsy (PB) Gleason score (GS) being the most important factor. Biopsy to radical prostatectomy (RP) specimen upgrading/downgrading is well described, and is often the ration...

Full description

Bibliographic Details
Main Authors: Muammer Altok, Patricia Troncoso, Mary F Achim, Surena F Matin, Graciela N Gonzalez, John W Davis
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Asian Journal of Andrology
Subjects:
biopsy; downgrade; gleason score; prostate cancer; upgrade
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=6;spage=598;epage=604;aulast=Altok

Internet

http://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=6;spage=598;epage=604;aulast=Altok

Similar Items